ScienceDaily (Dec. 15, 2008) — More than half of younger mantle cell lymphoma patients who received an intensive regimen of chemotherapy as frontline treatment remain in remission seven years later, researchers at The University of Texas M. D. Anderson Cancer Center report December 9 at the 50th annual meeting of the American Society of Hematology.
